COVAX, known as the COVID-19 Vaccine Implementation Program, is co-led by the Coalition for Epidemic Prevention and Innovation (CEPI), the Vaccine Alliance (Gavi) and the World Health Organization (WHO) to ensure equitable access to the COVID-19 vaccine for all participating countries and economies. To date, COVAX has delivered more than 435 million doses of COVID-19 vaccine to 144 countries.
To enable Bangladesh, where more than 10 million doses of COVID-19 vaccine will be used for local vaccination, to receive, store and distribute large quantities of COVID-19 vaccine requiring ultra-low temperature storage, 26 Haier Biomedical ultra-low temperature refrigerators were successfully delivered by COVAX, each capable of storing more than 300,000 doses of COVID-19 vaccine and able to support the use of these vaccines outside of the capital Dhaka. Due to the additional ultra-low temperature chain capacity, 2.5 million doses of Pfizer vaccines have been donated to Bangladesh were able to be shipped.
The delivery of 26 ultra-low temperature freezers to Bangladesh is part of UNICEF’s global target of delivering 350 ultra-low temperature freezers to more than 45 countries on behalf of COVAX. © UNICEF/UN0527479/Sujan
Corporate Social Responsibility is one of Haier Biomedical’s core values and Haier Biomedical is proud to be involved in the COVAX project in Bangladesh to enhance local vaccine storage capacity. Each ultra-low temperature freezer will play a key role in vaccine storage while ensuring that vaccines are equally accessible to all globally, especially in emerging economies.